BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18

Moomoo News55minutes ago · Ratings

Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick

Seeking Alpha12:46 ET

Unusual Options Activity: SPOT, MOD and Others Attract Market Bets, SPOT V/OI Ratio Reaches 90.4

Moomoo News11:30 ET

Hims & Hers Health Gain on Potential FDA Leadership Ties

Investing11:20 ET

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday

BenzingaNov 25 10:21 ET

Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?

BenzingaNov 24 10:20 ET